Long-term Health-Related Quality of Life and Outcomes after Hospitalization for COVID-19 in Brazil: Post-COVID Brazil 1 Study Protocol

BACKGROUNDThe long-term impact of hospitalization for COVID-19 on patients' physical, mental, and cognitive health still needs further assessment.OBJECTIVESThis study aims to evaluate factors associated with quality of life and cardiovascular and non-cardiovascular outcomes 12 months after hosp...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Arquivos brasileiros de cardiologia 2023-01, Vol.120 (11), p.e20230378-e20230378
Hauptverfasser: Trott, Geraldine, Scolari, Fernando Luis, Rover, Marciane Maria, Silva, Mariana Motta Dias da, Souza, Denise de, Santos, Rosa da Rosa Minho Dos, Schardosim, Raíne Fogliati de Carli, Rech, Gabriela Soares, Mesquita Neto, Juliana de, Estivalete, Gabriel Pozza, Freitas, Hellen Jordan Martins, Itaqui, Carolina Rothmann, Kozesinski-Nakatani, Amanda Christina, Biolo, Andreia, Marcolino, Milena Soriano, Barreto, Bruna Brandão, Schvartzman, Paulo Roberto, Antonio, Ana Carolina Peçanha, Robinson, Caroline Cabral, Falavigna, Maicon, Polanczyk, Carisi Anne, Rosa, Regis Goulart
Format: Artikel
Sprache:eng ; por
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:BACKGROUNDThe long-term impact of hospitalization for COVID-19 on patients' physical, mental, and cognitive health still needs further assessment.OBJECTIVESThis study aims to evaluate factors associated with quality of life and cardiovascular and non-cardiovascular outcomes 12 months after hospitalization for COVID-19.METHODSThis prospective multicenter study intends to enroll 611 patients hospitalized due to COVID-19 (NCT05165979). Centralized telephone interviews are scheduled to occur at three, six, nine, and 12 months after hospital discharge. The primary endpoint is defined as the health-related quality-of-life utility score assessed by the EuroQol-5D-3L (EQ-5D-3L) questionnaire at 12 months. Secondary endpoints are defined as the EQ-5D-3L at three, six and nine months, return to work or education, persistent symptoms, new disabilities in instrumental activities of daily living, cognitive impairment, anxiety, depression, and post-traumatic stress symptoms, major cardiovascular events, rehospitalization, as well as all-cause mortality at 3, 6, 9, and 12 months after SARS-CoV-2 infection. A p-value
ISSN:1678-4170
DOI:10.36660/abc.20230378